Fibrinolytic System in Adolescents: Response to Venous Occlusion Stress Tests
暂无分享,去创建一个
[1] S. Thorsen,et al. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis. , 2009, Scandinavian journal of haematology.
[2] R. Freedom,et al. Enhanced Thrombin Regulation during Warfarin Therapy in Children Compared to Adults , 1998, Thrombosis and Haemostasis.
[3] P. Monagle,et al. Morphological and Biochemical Features Affecting the Antithrombotic Properties of the Aorta in Adult Rabbits and Rabbit Pups , 1998, Thrombosis and Haemostasis.
[4] G. Lowe,et al. Prediction of Postoperative Deep-Vein Thrombosis , 1997, Thrombosis and Haemostasis.
[5] J. Paramo,et al. Evaluation of the fibrinolytic system in full-term neonates , 1995, International journal of clinical & laboratory research.
[6] F. Ofosu,et al. α2-Macroglobulin Remains as Important as Antithrombin III for Thrombin Regulation in Cord Plasma in the Presence of Endothelial Cell Surfaces , 1995, Pediatric Research.
[7] G. Pohl,et al. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA. , 1995, Thrombosis research.
[8] M. Bernstein,et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE , 1994 .
[9] F. Ofosu,et al. Maturation of the hemostatic system during childhood. , 1992, Blood.
[10] Boscoe M. Paes,et al. Fibrin Clot Lysis by Thrombolytic Agents Is Impaired in Newborns due to a Low Plasminogen Concentration , 1992, Thrombosis and Haemostasis.
[11] D. Keber,et al. Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis. , 1991, Thrombosis research.
[12] H. Büller,et al. Deep Vein Thrombosis and Fibrinolysis , 1991, Thrombosis and Haemostasis.
[13] H. Niwano,et al. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion , 1991, American journal of hematology.
[14] A. Jaffe,et al. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. , 1990, Circulation.
[15] P. Powers,et al. Development of the human coagulation system in the full-term infant. , 1987, Blood.
[16] T. Wun,et al. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level. , 1987, Blood.
[17] T. Kooistra,et al. Effect of Thrombin on the Production of Plasminogen Activators and PA Inhibitor-1 by Human Foreskin Microvascular Endothelial Cells , 1987, Thrombosis and Haemostasis.
[18] P. Philips,et al. Indicators of depressed fibrinolytic activity in pre‐operative prediction of deep venous thrombosis , 1987, The British journal of surgery.
[19] M. Jørgensen,et al. Increased concentration of the fast‐acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis , 1987, British journal of haematology.
[20] C. Forbes,et al. Association Between Postoperative Hyper-Response in t-PA Inhibition and Deep Vein Thrombosis , 1986, Thrombosis and Haemostasis.
[21] I. Nilsson. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis , 1985, British medical journal.
[22] Assist. Prof. D Keber. On the Use of Different Correction Factors for Hemoconcentration , 1983, Thrombosis and Haemostasis.
[23] M. Hoylaerts,et al. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.
[24] D. Collen. On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.
[25] A. Smokovitis. Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. , 1978, Haemostasis.
[26] R. Santler,et al. [Fibrinolytic activity of the vein wall]. , 1977, Phlebologie.
[27] C. Ruckley,et al. Plasma fibrinolysis and postoperative deep vein thrombosis , 1976, The British journal of surgery.
[28] M. Buckell. THE EFFECT OF CITRATE ON EUGLOBULIN METHODS OF ESTIMATING FIBRINOLYTIC ACTIVITY , 1958, Journal of clinical pathology.
[29] J. Freyssinet,et al. Assessment of the Fibrinolytic System , 1993 .
[30] M. Andrew,et al. Anticoagulation and thrombolysis in children. , 1992, Texas Heart Institute journal.
[31] F. Ofosu,et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. , 1992, The Journal of clinical investigation.
[32] D. Collen,et al. Basic and clinical aspects of fibrinolysis and thrombolysis. , 1991, Blood.